Going forward, PTS and Appspace are providing ongoing service and support, with a team ensuring the systems perform at peak ...

As you would probably expect from such a well-known name connected to the healthcare industry, the goals for GSK for this new ...

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...

GSK’s Blenrep combos are being reviewed in 14 nations. Credit: Magda Wygralak/Shutterstock. The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has authorised GSK’s Blenrep for ...

The British multinational pharmaceutical and biotechnology company GSK has officially opened its new regional vaccine distribution centre in Abu Dhabi to serve the demand across the Gulf ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in ...

Today, a brief rundown of news involving GSK and Bristol Myers Squibb, as well as updates from Elevation Oncology, Bayer and Airna that you may have missed. Novartis’s deal for Regulus is its second ...

The UK on Thurs­day au­tho­rized GSK’s Blenrep to treat cer­tain mul­ti­ple myelo­ma pa­tients in two dif­fer­ent reg­i­mens, mark­ing the drug’s first ap­proval world­wide ...

GSK has secured the first regulatory approval for Blenrep since the antibody-drug conjugate’s global market withdrawal in 2022. The U.K.’s Medicines and Healthcare products Regulatory Agency ...

The recommendation also includes GSK plc’s (NYSE:GSK) Arexvy in adults aged 50-59 who are at increased risk for severe RSV disease. This expands on ACIP’s previous vote in June 2024 to ...

Some Delaware Supreme Court justices signaled they may be skeptical of a bid by GSK Plc, Pfizer Inc. and other drugmakers to overturn a judge who allowed more than 80,000 lawsuits to proceed to ...